Results by group12

Each measurement the trial posted, group by group, in the words and numbers it posted.

1 to 12 of 12

Outcome	Group	Value	Units
Disease-free Survival	Group 2 Letrozole	84.7	percentage of patients free of disease
Disease-free Survival	Group 1 Placebo	81.3	percentage of patients free of disease
Overall Survival	Group 2 Letrozole	91.8	percentage of patients alive
Overall Survival	Group 1 Placebo	92.3	percentage of patients alive
Breast Cancer-free Interval	Group 2 Letrozole	6.7	percentage of patients
Breast Cancer-free Interval	Group 1 Placebo	10	percentage of patients
Distant Recurrence	Group 2 Letrozole	3.9	percentage of patients
Distant Recurrence	Group 1 Placebo	5.8	percentage of patients
Osteoporotic-related Fractures	Group 2 Letrozole	5.4	percentage of patients
Osteoporotic-related Fractures	Group 1 Placebo	4.8	percentage of patients
Arterial Thrombotic Events	Group 2 Letrozole	4.0	percentage of patients
Arterial Thrombotic Events	Group 1 Placebo	3.4	percentage of patients

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00382070/results